These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19336725)

  • 1. ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.
    Hasina R; Martin LE; Kasza K; Jones CL; Jalil A; Lingen MW
    Cancer Prev Res (Phila); 2009 Apr; 2(4):385-93. PubMed ID: 19336725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
    Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB
    Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.
    Zhou G; Hasina R; Wroblewski K; Mankame TP; Doçi CL; Lingen MW
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1493-502. PubMed ID: 20978113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
    Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):301-13. PubMed ID: 14734483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma.
    Peyser ND; Wang L; Zeng Y; Acquafondata M; Freilino M; Li H; Sen M; Gooding WE; Satake M; Wang Z; Johnson DE; Grandis JR
    Cancer Prev Res (Phila); 2016 Aug; 9(8):657-63. PubMed ID: 27267892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.
    Leeman-Neill RJ; Seethala RR; Singh SV; Freilino ML; Bednash JS; Thomas SM; Panahandeh MC; Gooding WE; Joyce SC; Lingen MW; Neill DB; Grandis JR
    Cancer Prev Res (Phila); 2011 Feb; 4(2):230-7. PubMed ID: 21163936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Yamamoto K; Kitayama W; Denda A; Morisaki A; Kuniyasu H; Inoue M; Kirita T
    Exp Toxicol Pathol; 2004 Dec; 56(3):145-51. PubMed ID: 15625783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC.
    Osei-Sarfo K; Tang XH; Urvalek AM; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2013 Nov; 34(11):2673-81. PubMed ID: 23784083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
    Tang XH; Albert M; Scognamiglio T; Gudas LJ
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1100-10. PubMed ID: 19952362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene.
    Tanaka T; Makita H; Ohnishi M; Hirose Y; Wang A; Mori H; Satoh K; Hara A; Ogawa H
    Cancer Res; 1994 Sep; 54(17):4653-9. PubMed ID: 8062259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Makita H; Mutoh M; Maruyama T; Yonemoto K; Kobayashi A; Fujitsuka H; Toida M; Shibata T; Miyamoto S; Yasui Y; Suzuki R; Wakabayashi K; Tanaka T
    Carcinogenesis; 2007 Mar; 28(3):677-84. PubMed ID: 17052996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model.
    Czerninski R; Amornphimoltham P; Patel V; Molinolo AA; Gutkind JS
    Cancer Prev Res (Phila); 2009 Jan; 2(1):27-36. PubMed ID: 19139015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
    Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
    J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Ethanol and 4-Nitroquinoline-1-Oxide Induced Epigenetic and Oxidative Stress Markers During Oral Cavity Carcinogenesis.
    Urvalek AM; Osei-Sarfo K; Tang XH; Zhang T; Scognamiglio T; Gudas LJ
    Alcohol Clin Exp Res; 2015 Aug; 39(8):1360-72. PubMed ID: 26207766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis.
    Yang Y; Ge JP; Zhou ZT
    J Oral Pathol Med; 2009 May; 38(5):455-62. PubMed ID: 19141066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases.
    Makita H; Tanaka T; Ohnishi M; Tamai Y; Torihara M; Yamahara J; Mori H; Satoh K; Hara A
    Carcinogenesis; 1995 Sep; 16(9):2171-6. PubMed ID: 7554071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.
    Shi Y; Xie TX; Leach DG; Wang B; Young S; Osman AA; Sikora AG; Ren X; Hartgerink JD; Myers JN; Rangel R
    Cancer Prev Res (Phila); 2021 Aug; 14(8):767-778. PubMed ID: 34021022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.
    Melis M; Zhang T; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2020 Nov; 41(11):1553-1564. PubMed ID: 32115621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.
    Monteiro de Oliveira Novaes JA; Hirz T; Guijarro I; Nilsson M; Pisegna MA; Poteete A; Barsoumian HB; Fradette JJ; Chen LN; Gibbons DL; Tian X; Wang J; Myers JN; McArthur MJ; Bell D; William WN; Heymach JV
    Cancer Prev Res (Phila); 2021 Mar; 14(3):313-324. PubMed ID: 33277316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate exhibits a high potential to suppress the formation of squamous cell carcinoma in an oral-specific 4-nitroquinoline 1-oxide/arecoline mouse model.
    Chang NW; Tsai MH; Lin C; Hsu HT; Chu PY; Yeh CM; Chiu CF; Yeh KT
    Biochim Biophys Acta; 2011 Apr; 1812(4):558-64. PubMed ID: 21081159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.